文献速递甲状腺疾病

弹性成像提升ACR TI-RADS对甲状腺结节的诊断准确性

Elastography Enhances Diagnostic Accuracy of ACR TI-RADS in Thyroid Nodule Evaluation.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

这项前瞻性研究纳入556例甲状腺结节≥10 mm的成人患者,评估在ACR TI-RADS基础上联合人口学信息、彩色多普勒超声(CDUS)和应变弹性成像(SE)能否改善恶性风险分层。以弹性成像比值(ER)阈值作为细针穿刺(FNA)附加标准,使穿刺数从501例降至260例且未漏诊恶性病例;在ACR TI-RADS 3类结节中鉴别性能优异。

要点

  • 在ACR TI-RADS基础上加用弹性成像比值可减少不必要的FNA。
  • 按ER阈值附加标准后FNA由501例降至260例,未遗漏恶性病例。
  • 弹性成像在ACR TI-RADS 3类结节中区分性能优异。

核心结论

  • 将弹性成像整合入ACR TI-RADS框架可优化甲状腺结节管理中的FNA使用,减少不必要的穿刺活检。

研究设计与样本

  • 前瞻性研究,纳入556例甲状腺结节≥10 mm、按ACR TI-RADS建议转诊行FNA的成人患者。
  • 所有结节行标准化超声评估,并用CDUS和SE评估血管性,细胞学按Bethesda系统分析。
  • 可获得时以手术病理作为恶性金标准。

主要发现

  • 以ER阈值(ACR TI-RADS 3、4、5类分别为>1.60、>0.44、>0.54)作为FNA附加标准,使操作数从501例降至260例,且未漏诊任何恶性病例。
  • 弹性成像在ACR TI-RADS 3类结节中区分性能优异(Youden指数0.994,曲线下面积0.994)。

关键数值与推荐

  • ER阈值:ACR TI-RADS 3类>1.60,4类>0.44,5类>0.54,作为FNA附加标准。
  • ACR TI-RADS 3类结节弹性成像Youden指数0.994,曲线下面积0.994。

临床怎么用

  • 对按ACR TI-RADS建议拟行FNA的甲状腺结节,可加做应变弹性成像并计算ER,按分类对应阈值辅助决定是否穿刺,以减少不必要FNA。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) incorporates conventional grayscale ultrasonography (US) as the only imaging technique without considering the clinical and demographic characteristics of patients. OBJECTIVE: This study assessed whether the addition of demographic information, color Doppler US (CDUS), and strain elastography (SE) could enhance malignancy risk stratification beyond the current ACR TI-RADS criteria. METHODS: This prospective study enrolled 556 adult patients with thyroid nodules 10 mm or greater who were referred for fine-needle aspiration (FNA) according to the ACR TI-RADS recommendations. All nodules underwent standardized US evaluations and vascularity assessments using CDUS and SE, with cytological analysis performed according to the Bethesda system. Surgical pathology was the gold standard for malignancy when available. RESULTS: Applying elastography ratio (ER) thresholds (>1.60, >0.44, and >0.54 for ACR TI-RADS categories 3, 4, and 5, respectively) as an additional criterion for FNA reduced the number of procedures from 501 to 260, without missing any malignant cases. Notably, elastography demonstrated an excellent discriminative performance in ACR TI-RADS 3 nodules (Youden index 0.994, area under the curve 0.994), supporting its value in improving risk stratification in this challenging, predominantly benign category. CONCLUSION: Integrating elastography into the ACR TI-RADS framework can optimize FNA utilization in the management of thyroid nodules by reducing the number of unnecessary aspiration biopsies.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Angelopoulos N, Goulis DG, Chrisogonidis I, et al. Elastography Enhances Diagnostic Accuracy of ACR TI-RADS in Thyroid Nodule Evaluation. J Clin Endocrinol Metab. 2026. PMID: 41409005. doi:10.1210/clinem/dgaf670

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。